Skip to main content
. 2020 Sep 29;20:370. doi: 10.1186/s12877-020-01725-2

Table 1.

Characteristics of study participants

Characteristic All participants (n = 82)1 Participants who contributed qualitative interviews2 (n = 17)
Age (median (Interquartile range (IQR))) 84 (79–89) 82 (81–86)
Gender
 Male n (%) 30 (37) 8 (47)
 Female n (%) 52 (63) 9 (53)
Number of hospital admissions (median (IQR))
 In 6 months prior to study 2 (1–3) 1 (1–3)
 During study 1 (0–2) 1 (0–2)
Elixhauser comorbidity score (median (IQR)) 3 (2–5) 4 (3–5)
Presence of cognitive impairment3 n (%) 19 (23) 4 (22)
CFS4 (median (IQR))
 Baseline 6 (5–6) 6 (5–7)
 12 weeks 6 (5–6) 6 (5–6)
 24 weeks 6 (5–6) 6 (5–7)
AKPS5(median (IQR))
 Baseline 50 (50–60) 50 (50–60)
 12 weeks 60 (50–60) 60 (50–60)
 24 weeks 60 (50–60) 50 (40–60)
Income status n (%)
 Living comfortably on current income 41 (50) 9 (53)
 Coping on current income 32 (39) 8 (47)
 Difficult on current income 4 (5) 0 (0)
 Very difficult on current income 1 (1) 0 (0)
 Don’t know 2 (2) 0 (0)
 Prefer not to say 2 (2) 0 (0)
Religious n (%)
 Yes 60 (73) 10 (59)
 No 21 (26) 7 (419)
 Missing 1 (1) 0 (0)
Living status n (%)
 Lives alone 43 (52.4) 8 (47)
 Lives with someone 39 (47.6) 9 (53)
Ethnicity n (%)
 White British 70 (85) 17 (100)
 White other 2 (2) 0 (0)
 Irish 3 (4) 0 (0)
 Caribbean 4 (5) 0 (0)
 African 1 (1) 0 (0)
 Other 1 (1) 0 (0)
 Missing 1 (1) 0 (0)

190 participants consented, but 8 required a proxy respondent and could not answer the preferences questions. Details of the 82 participants who answered the baseline survey are reported here. 2One participant was sampled for qualitative interviews but was unable to complete. 3Includes dementia, delirium, and cognitive impairment without formal diagnosis. 4CFS = Rockwood Clinical Frailty Scale 5AKPS = Australian modified Karnofsky Performance Status